» Articles » PMID: 20553862

Identification of Inhibitor Concentrations to Efficiently Screen and Measure Inhibition Ki Values Against Solute Carrier Transporters

Overview
Journal Eur J Pharm Sci
Specialties Chemistry
Pharmacology
Date 2010 Jun 18
PMID 20553862
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The objective was to identify inhibitor concentrations to efficiently screen and measure inhibition K(i) values of solute carrier (SLC) transporters. The intestinal bile acid transporter and its native substrate taurocholate were used as a model system. Inhibition experiments were conducted using 27 compounds. For each compound, the inhibition constant K(i) was obtained from the comprehensive inhibition profile, and referred as the reference K(i). K(i) values were also estimated from various partial profiles and were compared to the reference K(i). A screening K(i) was estimated from one data point and also compared to the reference K(i). Results indicate that K(i) can be accurately measured using an inhibitor concentration range of only 0-K(i) via five different inhibitor concentrations. Additionally, a screening concentration of 10-fold the substrate affinity K(t) for potent inhibitors (K(i)<20K(t)) and 100-fold K(t) for nonpotent inhibitors (K(i)>20K(t)) provided an accurate K(i) estimation. Results were validated through inhibition studies of two other SLC transporters. In conclusion, experimental conditions to screen and measure accurate transporter inhibition constant K(i) are suggested where a low range of inhibitor concentrations can be used. This approach is advantageous in that minimal compound is needed to perform studies and accommodates compounds with low aqueous solubility.

Citing Articles

Novel pyrazole and imidazolone compounds: synthesis, X-ray crystal structure with theoretical investigation of new pyrazole and imidazolone compounds anticipated insecticide's activities against and .

Shalaby M, BinSabt M, Rizk S, Fahim A RSC Adv. 2024; 14(15):10464-10480.

PMID: 38567329 PMC: 10985537. DOI: 10.1039/d4ra00602j.


Enhanced Antioxidant and Neuroprotective Properties of Pterostilbene (Resveratrol Derivative) in Amorphous Solid Dispersions.

Rosiak N, Tykarska E, Cielecka-Piontek J Int J Mol Sci. 2024; 25(5).

PMID: 38474022 PMC: 10932125. DOI: 10.3390/ijms25052774.


Prediction of Phytochemicals for Their Potential to Inhibit New Delhi Metallo β-Lactamase (NDM-1).

Bibi Z, Asghar I, Ashraf N, Zeb I, Rashid U, Hamid A Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895875 PMC: 10610165. DOI: 10.3390/ph16101404.


Identification of Sesamin from as a Potent Antifungal Agent Using an Integrated in Silico and Biological Screening Platform.

Wadhwa K, Kaur H, Kapoor N, Brogi S Molecules. 2023; 28(12).

PMID: 37375219 PMC: 10304600. DOI: 10.3390/molecules28124658.


Proteome-Based Investigation Identified Potential Drug Repurposable Small Molecules Against Monkeypox Disease.

Bhattacharjee A, Ahammad I, Chowdhury Z, Das K, Keya C, Salimullah M Mol Biotechnol. 2022; 66(4):626-640.

PMID: 36357534 PMC: 9648865. DOI: 10.1007/s12033-022-00595-w.


References
1.
Murphy D . Determination of accurate KI values for tight-binding enzyme inhibitors: an in silico study of experimental error and assay design. Anal Biochem. 2004; 327(1):61-7. DOI: 10.1016/j.ab.2003.12.018. View

2.
Ayrton A, Morgan P . Role of transport proteins in drug discovery and development: a pharmaceutical perspective. Xenobiotica. 2008; 38(7-8):676-708. DOI: 10.1080/00498250801923855. View

3.
Han H, de Vrueh R, Rhie J, Covitz K, Smith P, Lee C . 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res. 1998; 15(8):1154-9. DOI: 10.1023/a:1011919319810. View

4.
Balimane P, Tamai I, Guo A, Nakanishi T, Kitada H, Leibach F . Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. Biochem Biophys Res Commun. 1998; 250(2):246-51. DOI: 10.1006/bbrc.1998.9298. View

5.
Zheng X, Ekins S, Raufman J, Polli J . Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter. Mol Pharm. 2009; 6(5):1591-603. PMC: 2757534. DOI: 10.1021/mp900163d. View